A 23year old female patient is having excess white discharge from 4-5days
vaginal discharge vaginitis diagnosis management
| Question | Significance |
|---|---|
| Colour of discharge (white, grey, green, yellow) | Differentiates causes |
| Odour (fishy vs. none) | BV vs. candidiasis |
| Itching / burning | Strongly suggests candidiasis |
| Sexual activity / new partner | Trichomoniasis, STIs |
| Recent antibiotic use | Precipitates candidiasis |
| Dysuria / dyspareunia | Severity assessment |
| Last menstrual period | Physiological vs. pathological |
| Fever / lower abdominal pain | Suggests PID |
| Diabetes / immunosuppression | Risk factor for candidiasis |
| Test | Finding | Diagnosis |
|---|---|---|
| Vaginal pH | > 4.5 | BV or Trichomoniasis |
| Saline wet mount | Clue cells (>20%) | BV (Sens 74%, Spec 86%) |
| Saline wet mount | Motile trichomonads | Trichomoniasis (Spec 100%) |
| KOH (10%) wet mount | Hyphae / pseudohyphae | Candidiasis |
| Whiff test (KOH + discharge) | Fishy amine odour | BV (Sens 67%, Spec 93%) |
| NAAT (vaginal/urine) | T. vaginalis | Trichomoniasis (Sens 95-100%) |
| Gram stain | Reduced Lactobacilli, Gardnerella | BV |
20% clue cells on wet mount
| Condition | First-line Treatment |
|---|---|
| Bacterial Vaginosis | Oral metronidazole 500 mg BD x 7 days, OR intravaginal metronidazole gel, OR intravaginal clindamycin cream |
| Vulvovaginal Candidiasis | Short course topical antifungal (clotrimazole, miconazole), OR single dose oral fluconazole 150 mg |
| Trichomoniasis | Metronidazole 2g single dose OR tinidazole 2g single dose; treat partner simultaneously |
| Physiological | Reassurance; no treatment needed |
Note: For trichomoniasis, partner treatment is mandatory and sexual intercourse should be avoided until both partners complete treatment and symptoms resolve.
She had sex and after it she took northeisterone tablet and the next day period came
norethisterone vaginal discharge hormonal effects
norethisterone tablet after sex period next day white discharge mechanism
Unprotected sex → Norethisterone tablet taken → Period came next day → White discharge (4-5 days)
Critical note: Norethisterone is NOT an emergency contraceptive. It does not prevent pregnancy. Many patients take it after unprotected sex believing it works like a "morning-after pill," but this is incorrect.
| Cause | Explanation |
|---|---|
| Post-menstrual physiological discharge | Normal clear-to-white discharge resumes after a period as oestrogen rises in the follicular phase |
| Norethisterone-induced cervical mucus changes | Progestogens alter cervical mucus - becoming thicker and more prominent; this can persist after stopping the tablet |
| Hormonal disruption | A single dose of norethisterone disrupts the normal cycle pattern, potentially altering discharge character for 1-2 weeks |
| Infection | Discharge Character | Other Features |
|---|---|---|
| Bacterial Vaginosis | White/grey, thin, fishy odour | No/minimal itch |
| Vulvovaginal Candidiasis | White, thick, curdy | Itching, burning |
| Chlamydia / Gonorrhoea (cervicitis) | White/yellow, mucopurulent | Often asymptomatic |
| Trichomoniasis | Frothy, yellow-green | Odour, irritation |
No itching no burning
| Cause | Why it fits | Key feature |
|---|---|---|
| Physiological / hormonal discharge | Post-period + norethisterone-induced cervical mucus change | White, odourless, no symptoms |
| Bacterial Vaginosis | Most common pathological white discharge without itch | May have mild fishy odour |
| Chlamydial cervicitis | Often completely asymptomatic - "silent STI" | Mucopurulent discharge from os, no itch |
Generate a STI screening checklist for this patient 3-4days
ls -la /home/daytona/workspace/ 2>/dev/null || mkdir -p /home/daytona/workspace && ls -la /home/daytona/workspace/
Her cycle was about to come in 3-4 days from the day she took pill
Day 0: Unprotected sex → Norethisterone tablet taken (cycle due in 3-4 days)
Day 1: Period came
Day 2-6: White discharge (4-5 days, no itch, no burn)
| Timing | Significance |
|---|---|
| Sex occurred in late luteal phase (3-4 days before period) | Very low fertility window - ovulation was ~10-14 days prior |
| Norethisterone taken at this stage | Does NOT act as contraception regardless |
| Period came next day as expected | Strongly suggests normal cycle, ovulation had already passed |
| Diagnosis | Probability | Reasoning |
|---|---|---|
| Physiological post-menstrual discharge | Very high | Timing fits perfectly, no symptoms |
| Norethisterone cervical mucus effect | High | Known side effect, temporal relation |
| Bacterial Vaginosis | Low-moderate | No odour mentioned, but possible |
| Chlamydial cervicitis | Low but must screen | Asymptomatic in 70% of women |
| Candidiasis | Very unlikely | No itch, no burning |
| Pregnancy | Very low | Sex in late luteal phase, period came |
A 23year old female wants a laser for rapid growth of ingrown hairs over chin
laser hair removal hirsutism PCOS
PMID: 38630483
Do not proceed to laser without investigating the cause. Laser on an active hormonal drive will give poor, temporary results and the underlying condition will be missed.
| Cause | Key Features |
|---|---|
| Non-classic Congenital Adrenal Hyperplasia (NCAH) | Mimics PCOS; elevated 17-OHP |
| Cushing Syndrome | Central obesity, striae, HTN, moon face |
| Androgen-secreting ovarian/adrenal tumour | Rapid onset, virilization - this case has "rapid growth" - must exclude |
| Hyperprolactinaemia | Galactorrhoea, amenorrhoea, anovulation |
| Idiopathic hirsutism | Normal androgens, regular cycles - diagnosis of exclusion |
"Rapid and rapidly progressing signs of androgen excess require careful investigation for an androgen-secreting neoplasm" - Berek & Novak's Gynecology, p. 1906
| Test | Purpose | Normal Range |
|---|---|---|
| Total Testosterone | Androgen excess | 20-80 ng/dL |
| Free Testosterone (calculated) | Bioactive fraction | 0.6-6.8 pg/mL |
| DHEAS | Adrenal androgen source | 100-350 µg/dL |
| Androstenedione | Androgen precursor | 20-250 ng/dL |
| SHBG | Low in PCOS/insulin resistance | 18-114 nmol/L |
| 17-OHP (follicular phase) | Exclude NCAH | <300 ng/dL = likely unaffected |
| Prolactin | Exclude hyperprolactinaemia | - |
| TSH | Thyroid dysfunction | - |
| Fasting insulin + glucose | Insulin resistance in PCOS | - |
| Laser Type | Wavelength | Notes |
|---|---|---|
| Alexandrite laser | 755 nm | Best evidence for hirsutism in PCOS; effective at high fluence |
| Diode laser | 810 nm | Effective; safer for darker skin types (Fitzpatrick IV-VI) |
| Nd:YAG | 1064 nm | Best for dark skin (Fitzpatrick V-VI); less risk of dyspigmentation |
| IPL (Intense Pulsed Light) | Broadband | Less effective than alexandrite/diode laser |
Step 1 → Hormonal workup + pelvic ultrasound
Step 2 → Diagnose cause (PCOS most likely)
Step 3 → Start systemic treatment:
- Combined OCP (reduces ovarian androgen production - reduces hair growth
in ~2/3 of hirsute patients)
- ± Metformin (if insulin resistance/PCOS)
- ± Spironolactone/cyproterone acetate (anti-androgen)
Step 4 → Laser hair reduction (alexandrite or diode) as adjunct
- Works significantly better WITH hormonal treatment than alone
Step 5 → Reassess Ferriman-Gallwey score at 6 months
Create a hormonal treatment algorithm for PCOS-related hirsutism
PCOS hirsutism treatment guidelines antiandrogen
A clean, professional medical clinical algorithm flowchart titled "Hormonal Treatment Algorithm: PCOS-Related Hirsutism" with a white background and clear box-and-arrow flowchart design. The algorithm flows top to bottom with these steps: TOP BOX (blue header): "Confirmed PCOS-Related Hirsutism" with subtitle "Ferriman-Gallwey score >8, androgens elevated, PCO morphology" STEP 1 BOX (green): "Step 1 – Lifestyle Modification (ALL patients)" with bullet points: "• Weight loss 5–7% body weight if obese", "• Exercise targeting large muscle groups", "• Reduces insulin resistance, free testosterone, restores ovulation" DECISION DIAMOND: "Does patient desire pregnancy?" LEFT BRANCH – "No (Contraception acceptable)": STEP 2A BOX (blue): "FIRST LINE: Combined Oral Contraceptive Pill (OCP)" with details: "• Low-androgenic progestin preferred (drospirenone, desogestrel, norgestimate)", "• Increases SHBG → reduces free testosterone", "• Suppresses LH → reduces ovarian androgen", "• Reduces hair growth in ~2/3 of patients", "• Reassess at 6 months" STEP 3A BOX (orange): "Inadequate response at 6 months? → ADD Antiandrogen" with two columns: "Spironolactone 50–200mg/day – First choice, androgen receptor blocker" and "Cyproterone Acetate 2–100mg/day – Not available in US, very effective with EE" STEP 4A BOX (purple): "If still inadequate or severe hyperandrogenaemia:" with bullets: "• Add Metformin 850mg BD (if insulin resistance present)", "• GnRH agonist (Leuprolide 7.5mg/month IM) + oestrogen add-back", "• Finasteride 1–5mg/day (5α-reductase inhibitor)" RIGHT BRANCH – "Yes (Fertility desired)": STEP 2B BOX (teal): "FIRST LINE: Metformin" with details: "• 500mg TDS or 850mg BD", "• Improves insulin resistance", "• Reduces androgens, restores ovulation", "• Safe in pregnancy (Category B)" STEP 3B BOX (orange): "If hirsutism persists:" with bullets: "• Clomiphene citrate (ovulation induction)", "• Low-dose OCP cycles between conception attempts", "• Avoid antiandrogens (teratogenic)" BOTTOM BOX (red border): "ALL CASES: Adjunctive Laser Hair Removal" with bullets: "• Alexandrite or Diode laser – 6–8 sessions", "• MORE effective when combined with OCP + Metformin", "• Topical Eflornithine for facial hair (inhibits ornithine decarboxylase)" IMPORTANT NOTE BOX (yellow): "Note: All antiandrogens (spironolactone, cyproterone, flutamide, finasteride) are TERATOGENIC – contraception mandatory. Clinical response takes 6–12 months." Use professional medical diagram styling with color-coded boxes, clear directional arrows, clean sans-serif font, and appropriate spacing.

| Line | Drug | Dose | Mechanism | Key Point |
|---|---|---|---|---|
| 1st | Combined OCP | 1 tablet daily | Raises SHBG, suppresses LH, inhibits 5α-reductase | Prefer low-androgenic progestin: drospirenone, desogestrel, norgestimate. Avoid norgestrel/norethindrone (androgenic) |
| 2nd (add-on) | Spironolactone | 50-200mg/day | Competitive AR blocker + inhibits 5α-reductase | Most studied antiandrogen; monitor K⁺; use with OCP |
| 2nd (alternative) | Cyproterone acetate | 2mg (in OCP) or 12.5-100mg | Competes with DHT at AR | More effective than OCP alone; not available in USA |
| 3rd | Finasteride | 1-5mg/day | 5α-reductase type 2 inhibitor | Reduces DHT at follicle; Pregnancy Category X |
| Severe/refractory | GnRH agonist (Leuprolide) | 7.5mg/month IM | Suppresses gonadotropins → ovarian androgen | Must add oestrogen add-back to prevent osteoporosis |
| If insulin resistance | Metformin | 850mg BD or 500mg TDS | Reduces hyperinsulinaemia → reduces ovarian androgens | Add to OCP for superior results |
| Line | Drug | Dose | Rationale |
|---|---|---|---|
| 1st | Metformin | 500mg TDS or 850mg BD | Safe in pregnancy, reduces androgens, restores ovulation |
| 2nd | Clomiphene citrate | 50-150mg Day 2-6 | Ovulation induction |
| Avoid | All antiandrogens | - | Teratogenic - absolutely contraindicated |
All antiandrogens are TERATOGENIC. Spironolactone (Category C), cyproterone, flutamide, finasteride (Category X) - reliable contraception is mandatory throughout treatment.
Response is slow - patients must be counselled that clinical improvement in hair growth takes 6-12 months. Existing terminal hairs do not regress; only new growth is suppressed.
A 23y f pt came to the opd with Hyperpigmented lips but she doesnt smoke
95% of patients have perioral lesions

⚠️ If this diagnosis is suspected, refer for GI endoscopy, colonoscopy, capsule endoscopy, and genetic testing immediately.
| Drug | Pattern |
|---|---|
| Antimalarials (chloroquine, hydroxychloroquine) | Diffuse skin + mucosal |
| Minocycline | Grey-blue skin, mucosa, nails |
| Cyclophosphamide | Diffuse skin + mucous membranes |
| Zidovudine (ART) | Mucosal + nail pigmentation |
| Amiodarone | Slate-grey photodistributed |
| Question | Targets |
|---|---|
| Family history of lip spots or GI polyps? | Peutz-Jeghers (autosomal dominant) |
| Episodes of abdominal pain, vomiting, rectal bleeding? | PJS polyps, intussusception |
| Fatigue, weight loss, postural dizziness, salt craving? | Addison's disease |
| Irregular periods, excess hair growth, acne? | PCOS (given previous context - very relevant) |
| Currently on OCP or hormonal therapy? | Melasma/chloasma |
| Vegetarian/vegan diet? | B12 deficiency |
| Cosmetic use - lipstick, balm, toothpaste? | Contact pigmentation |
| Any medications? | Drug-induced |
| When did it start? Childhood vs recent? | PJS (childhood) vs acquired |
| Is it macules (spots) or diffuse darkening? | PJS/Laugier = macules; Addison/PCOS = diffuse |
| Nail changes? | Laugier-Hunziker (melanonychia) |
| Test | Targets |
|---|---|
| 8 AM serum cortisol + ACTH | Addison's disease |
| CBC + peripheral smear | B12 deficiency (macrocytic anaemia) |
| Serum Vitamin B12 + Folate | Nutritional deficiency |
| Fasting glucose + insulin + HOMA-IR | PCOS/insulin resistance |
| Thyroid function (TSH) | Associated autoimmune disease |
| LH, FSH, testosterone, DHEAS | PCOS/hyperandrogenism |
| Test | Purpose |
|---|---|
| STK11 gene mutation testing | Confirm PJS diagnosis |
| Upper GI endoscopy + colonoscopy | Detect GI polyps |
| Capsule endoscopy (small bowel) | Small bowel polyps (most common site) |
| Pelvic ultrasound | Ovarian sex cord tumours in female PJS |
| Dermatoscopy of lesions | Characterise macule pattern |
| Priority | Diagnosis | Why |
|---|---|---|
| Must exclude first | Peutz-Jeghers Syndrome | Young woman, lip macules, high cancer stakes |
| Must exclude | Addison's Disease | Life-threatening if missed, classic distribution |
| Very relevant here | PCOS + insulin resistance | Given her previous history in this consultation |
| Common/benign | Laugier-Hunziker / contact / B12 deficiency | After serious causes excluded |
What lipbalm to prescribe
For mild-moderate lip hyperpigmentation (cause established as benign/cosmetic):
1. Kojic Acid 2% + Niacinamide 4% Lip Gel – apply BD (morning & night)
OR
Azelaic Acid 15% gel – apply OD at night
2. SPF 50 Lip Balm (e.g., La Roche-Posay Anthelios) – apply every morning,
reapply 2-hourly in sun
3. Review at 8 weeks
| Avoid | Reason |
|---|---|
| High-concentration hydroquinone (>2%) | Mucosal absorption, ochronosis risk |
| Tretinoin (retinoic acid) on lips | Severe irritation, mucosal sensitivity |
| Mercury-containing products | Toxic |
| Prolonged steroid-containing creams | Skin atrophy, systemic absorption |
How to use melitaine solution
melitane solution how to use cosmetic ingredient alpha-MSH tripeptide pigmentation
melitane topical solution instructions dermatology hyperpigmentation lips
melitane INCI ingredient cosmetic formulation usage percentage instructions seppic
https://www.ulprospector.com/en/na/PersonalCare/Detail/4501/…
Critical point: Melitane stimulates melanin synthesis - it is a pro-pigmentation agent, not a depigmenting one. It mimics alpha-MSH and activates MC1-R receptors to promote skin tanning and pigment formation. Prescribing this to a patient with hyperpigmented lips would worsen the condition.
| Property | Detail |
|---|---|
| INCI Name | Acetyl Hexapeptide-1 |
| Manufacturer | Lucas Meyer Cosmetics (Clariant) |
| Mechanism | Biomimetic alpha-MSH analog → activates MC1-R → stimulates melanogenesis → increases melanin production |
| Primary use | Promotes skin tanning/pigmentation, UV-induced erythema protection, DNA repair after UV exposure |
| Anti-aging benefit | Reduces UV-induced sunburn cells, limits inflammatory mediators |
| Indicated for | Patients with hypopigmentation, vitiligo support, sunless tanning formulations, UV protection products |
| Contraindicated for | Patients with existing hyperpigmentation - it will make dark lips/spots darker |
| You might mean | What it is | Used for |
|---|---|---|
| Melitane (Acetyl Hexapeptide-1) | Pro-pigmentation peptide | Tanning, UV protection - NOT for dark lips |
| Mela-Cream / Melalite (Hydroquinone 2-4%) | Depigmenting agent | Dark spots, melasma, lip hyperpigmentation |
| Melaglow / MelaFade | Kojic acid + arbutin combinations | Skin lightening |
| Melarase | Kojic + niacinamide cream | Hyperpigmentation treatment |
| Melatonik | Tranexamic acid serum | Melasma |
| Agent | Action |
|---|---|
| Kojic acid 2% | Tyrosinase inhibitor - lightens |
| Niacinamide 4-5% | Inhibits melanosome transfer - lightens |
| Azelaic acid 15-20% | Tyrosinase inhibitor - lightens |
| Hydroquinone 2% (short term) | Gold standard depigmenter |
| SPF 50 lip balm | Mandatory - prevents UV-driven worsening |
Melitraine altris 5
Altris 5 tretinoin cream India how to use instructions
Melitraine cream tretinoin hyperpigmentation India dermatology
Altris 5 cream tretinoin 0.05% uses side effects how to apply India brand
| Week | Frequency | Why |
|---|---|---|
| Weeks 1-2 | Every 3rd night (2x/week) | Allow skin to adjust |
| Weeks 3-4 | Every other night (3-4x/week) | Gradual increase |
| Weeks 5-6 | Every other night | Continue building |
| Weeks 7+ | Every night | Full maintenance dose |
If irritation is significant at any stage, drop back to every other night and build up again more slowly.
| Reaction | When | What to Do |
|---|---|---|
| Redness, mild stinging, dryness | First 2-4 weeks | Normal - continue, use more moisturiser |
| Peeling, flaking | Weeks 2-6 | Normal - do not scratch or pick; moisturise well |
| Temporary worsening of pigmentation | First few weeks | Normal (purge phase) - continue |
| Improved pigmentation | Weeks 8-12 | Expected result |
Do NOT apply Altris 5 directly on the vermilion lip surface. The lip mucosa has no stratum corneum and tretinoin will cause severe irritation, burning, and peeling on actual lip tissue. Apply only to the perioral skin (skin around the lips) for perioral hyperpigmentation. For pigmentation on the lip itself, use kojic acid + niacinamide lip balm + SPF as discussed.
Melitaine altris 5 hair solution
Altris 5 hair solution tretinoin minoxidil scalp India how to use
"Melitane" OR "Melitaine" hair solution scalp India brand ingredients
https://pmc.ncbi.nlm.nih.gov/articles/PMC6892010
| Property | Detail |
|---|---|
| Active ingredient | Melitane (Acetyl Hexapeptide-1) 5% |
| Manufacturer | Alembic Pharmaceuticals, India |
| Formulation | Aqueous solution / spray, 60 ml |
| Mechanism | Activates MC1-R (melanocortin-1 receptor) → stimulates melanogenesis → promotes melanin production in hair follicles |
| Primary indication | Premature hair graying (Premature Canities) - reverses and prevents gray/white hair |
| Age group | Mainly recommended for ages 8-25 years (premature graying) |
| Parameter | Recommendation |
|---|---|
| Frequency | Once daily |
| Amount | ~2g / approx. 8-10 sprays per application |
| Time of application | Evening preferred (leave overnight for maximum absorption) |
| Duration of treatment | 4-6 months minimum before assessing response |
| Full response | Up to 24 months for significant hair repigmentation |
| Timeline | Expected Change |
|---|---|
| Weeks 1-4 | No visible change; melanocyte reactivation occurring internally |
| Months 2-3 | New hair growing from gray roots may appear darker at base |
| Months 4-6 | Visible improvement in dark regrowth of treated areas |
| Months 12-24 | Significant repigmentation (>95% conversion seen in published case) |
Patience is essential. Hair grows only ~1 cm/month - colour change at the root takes months to become visible as the hair shaft grows out.
| Nutrient | Role |
|---|---|
| Biotin | Hair shaft structural integrity |
| Calcium pantothenate (B5) | Melanocyte function |
| Copper | Essential cofactor for tyrosinase (melanin synthesis enzyme) |
| Zinc | Antioxidant, follicle health |
| Selenium | Reduces oxidative stress in follicles |
| Folic acid | DNA synthesis in rapidly dividing follicle cells |
| N-acetyl cysteine | Antioxidant, reduces hydrogen peroxide accumulation (key cause of graying) |
| Point | Detail |
|---|---|
| Not a dye | Restores natural melanin - works from the root; does not colour existing gray shafts |
| Evidence level | Limited - mainly case reports and industry studies; RCTs lacking |
| Age relevance | Best evidence in premature graying in young patients (<25 years); less evidence in age-related graying |
| Safe for | Coloured and chemically treated hair |
| Pregnancy | Consult doctor before use |
| No scalp irritation | Generally well tolerated; discontinue if rash develops |
How i can check a pt is pregnant or not
| Sign | Details | When |
|---|---|---|
| Amenorrhoea | Absence of periods - earliest and most important symptom | From conception |
| Morning sickness | Nausea/vomiting, usually morning, resolves in hours | Weeks 4-16 |
| Breast changes | Tingling, tenseness, enlargement, darkened nipples, Montgomery's tubercles, colostrum | From 2nd month |
| Quickening | First fetal movements felt by mother as "fluttering" | Weeks 16-20 |
| Skin pigmentation | Linea nigra, darkening of vulva, abdomen, axillae | 2nd trimester |
| Urinary frequency | Enlarging uterus presses on bladder | Early and late pregnancy |
| Fatigue | Easy tiredness | Early weeks |
| Chadwick's sign | Vaginal mucosa changes from pink → violet → blue due to venous congestion | From week 4 |
| Sympathetic symptoms | Excessive salivation, perverted appetite, mood changes | 1st trimester |
| Sign | Details | When |
|---|---|---|
| Abdominal enlargement | Uterus palpable above pelvis from 12 weeks; fundal height correlates with gestation (see below) | >12 weeks |
| Uterine changes | Enlargement, softening, change in shape | 6-8 weeks |
| Hegar's sign | Softening of the lower uterine segment (isthmus) - felt on bimanual examination | 6-10 weeks |
| Goodell's sign | Softening of the cervix | 6 weeks |
| Ballottement | Fetus "bounces" on gentle vaginal/abdominal tap | 4-5 months |
| Braxton Hicks contractions | Intermittent, painless uterine contractions | >4 months |
| Uterine souffle | Soft blowing murmur synchronous with maternal pulse on auscultation over uterus | End of 4th month |
| Weeks | Fundal Height |
|---|---|
| 12 weeks | Just above symphysis pubis |
| 16 weeks | Midway between symphysis and umbilicus |
| 20 weeks | At umbilicus |
| 28 weeks | Midway between umbilicus and xiphisternum |
| 36 weeks | At xiphoid cartilage |
| 40 weeks | Drops slightly (head engages) |
| Sign | Details | When |
|---|---|---|
| Fetal heart sounds | Heard with Pinard stethoscope from ~20 weeks; Doppler from ~10-12 weeks | 10-20 weeks |
| Fetal movements felt by examiner | Felt on abdominal palpation | >20 weeks |
| Ultrasound | Gestational sac visible, fetal pole, fetal cardiac activity | From 5-6 weeks (TVS) |
| Feature | Detail |
|---|---|
| Detected from | Day 8-10 post-conception (before missed period) |
| Level in early pregnancy | Doubles every 48-72 hours in normal IUP |
| Discriminatory zone | >1500-2000 mIU/mL → gestational sac should be visible on TVS |
| Use | Early pregnancy, ectopic exclusion, monitoring miscarriage |
| Timing | Findings |
|---|---|
| 5-6 weeks (TVS) | Gestational sac visible |
| 6 weeks (TVS) | Yolk sac visible |
| 6-7 weeks (TVS) | Fetal pole + cardiac activity |
| 10-12 weeks (TAS) | Fetal heart, CRL measurement |
Patient with possible pregnancy
|
▼
1. History: Last menstrual period, sexual activity,
symptoms (nausea, breast changes, missed period)
|
▼
2. Urine Pregnancy Test (UPT) - First morning urine
| |
POSITIVE NEGATIVE
| |
▼ ▼
3. Confirm with If suspicion high:
Serum beta-hCG Repeat UPT in 48-72 hrs
+ TVS/USG OR serum beta-hCG
|
▼
4. USG to confirm intrauterine pregnancy
(rule out ectopic), gestational age,
fetal viability (cardiac activity)
Her cycle is after 20days so i should wait because is having symptoms like constipation ,cramps , eating a lot but not pica
Unprotected sex → Norethisterone taken → Withdrawal bleed came next day
(cycle was due in 3-4 days anyway)
↓
Now: 20 days after that bleed → Symptoms present
| Symptom | Pregnancy? | Alternatively |
|---|---|---|
| Constipation | Yes - progesterone slows gut motility from early pregnancy | Also: PMS, low fibre diet, dehydration |
| Cramps | Yes - early implantation/uterine stretching | Also: Pre-menstrual cramps (her next period is DUE) |
| Increased appetite | Yes - early pregnancy hunger | Also: Luteal phase (PMS) increase in appetite |
| Not pica | Pica = eating non-food items (clay, chalk) - its absence doesn't rule out pregnancy |
Critical insight: These symptoms - constipation, cramps, increased appetite - are identical to late luteal phase / PMS symptoms. Progesterone rises in the luteal phase whether pregnant or not, and causes all three symptoms. You cannot clinically distinguish early pregnancy from PMS based on these symptoms alone.
If her cycle is due in 20 days, that means she is currently around Day 7-10 of her new cycle - which means she is either:
- Not pregnant (in which case symptoms = normal luteal/follicular phase)
- Or if she had sex in this current cycle around ovulation (~Day 14) - it is too early to test yet
Did she have unprotected sex again after the withdrawal bleed / after her period?
| Scenario | When to Test |
|---|---|
| Sex was only before the period that already came | Very low risk - test now if she wants reassurance; likely negative |
| Sex after the period (in this current cycle) | Wait until Day 1 of missed period - i.e., in ~20 days as you say |
| Sex around Day 10-14 of this current cycle | Test 14 days after that sex (or at missed period) |
| Action | Timing |
|---|---|
| Reassure now | Symptoms are consistent with normal cycle |
| Do UPT if she is anxious | Can do now - if negative at Day 20+, very reassuring |
| Repeat UPT if next period is missed | On Day 1 of missed period = most accurate |
| Counsel on contraception | This is the third time unprotected sex has come up - she needs reliable contraception going forward |
| Watch for red flags | Severe one-sided pelvic pain + bleeding = rule out ectopic (though very unlikely here) |
Sugar medication can be taken before food?
| Drug | Why Before Food |
|---|---|
| Glipizide (Glucotrol) | Stimulates insulin release - needs to act before glucose load arrives; take 30 min before meal |
| Glimepiride | Sulfonylurea - take with first bite or 15-30 min before breakfast |
| Repaglinide (Prandin) | Rapid-acting secretagogue - take 0-30 min before each meal; skip if skipping meal |
| Nateglinide (Starlix) | Take 1-30 min before meals; skip if meal skipped |
| Short-acting insulin (Regular) | Inject 30 min before meal |
| Rapid-acting insulin (Lispro, Aspart, Glulisine) | Inject 0-15 min before meal or immediately before |
⚠️ Sulfonylureas and meglitinides taken before food without eating = hypoglycaemia risk
| Drug | Why With Food |
|---|---|
| Metformin | Reduces GI side effects (nausea, diarrhoea) significantly when taken with meals; take with or after food |
| Glyburide/Glibenclamide | Take with breakfast or first main meal |
| Acarbose / Miglitol | Alpha-glucosidase inhibitors - MUST be taken with first bite of food; delays carbohydrate digestion at the intestinal brush border - useless if not taken with meal |
| Pioglitazone (Actos) | Thiazolidinedione - can be taken with or without food, but WITH food reduces GI upset |
| Drug | Notes |
|---|---|
| Metformin XR (extended release) | With evening meal to reduce GI side effects; otherwise flexible |
| Sitagliptin (DPP-4 inhibitor) | With or without food - no meal timing requirement |
| Vildagliptin, Saxagliptin, Alogliptin | With or without food |
| Empagliflozin, Dapagliflozin, Canagliflozin (SGLT2 inhibitors) | With or without food |
| Long-acting insulin (Glargine, Detemir, Degludec) | Same time each day - no relation to meals |
| GLP-1 agonists (Liraglutide, Dulaglutide - weekly injections) | Meal-independent |
| Drug Class | Example | Timing |
|---|---|---|
| Biguanide | Metformin | With or after food |
| Sulfonylurea (short-acting) | Glipizide | 30 min BEFORE food |
| Sulfonylurea (long-acting) | Glimepiride, Glyburide | With first meal |
| Meglitinide | Repaglinide | 0-30 min BEFORE each meal |
| Alpha-glucosidase inhibitor | Acarbose | With FIRST BITE of meal |
| Thiazolidinedione | Pioglitazone | With or without food |
| DPP-4 inhibitor | Sitagliptin | With or without food |
| SGLT2 inhibitor | Empagliflozin | With or without food |
| GLP-1 agonist (daily) | Liraglutide | Before any meal (consistent time) |
| Rapid insulin | Novorapid | 0-15 min BEFORE meal |
| Regular insulin | Actrapid | 30 min BEFORE meal |
| Basal insulin | Glargine | Meal-independent (fixed time) |
| Drug | Timing |
|---|---|
| Metformin 500/850/1000mg | After food - always, to prevent nausea |
| Glimepiride 1/2mg | Before breakfast |
| Glipizide 5mg | 30 min before food |
| Voglibose/Acarbose | With first bite of meal |
| Sitagliptin (Januvia) | Any time |
| Empagliflozin (Jardiance) | Any time (morning preferred) |
| Fixed dose combos (Metformin + Glimepiride) | After food (metformin timing takes priority) |
Key teaching point: When a fixed-dose combination contains metformin (e.g., Metformin + Glimepiride, Metformin + Sitagliptin), the instruction is always "after food" to protect against metformin-induced GI side effects - the metformin timing overrides the sulfonylurea timing in practice.
Metformin sr 500
| Feature | Metformin IR | Metformin SR 500 |
|---|---|---|
| Release | Immediate | Slow, over 6-8 hours |
| Frequency | 2-3 times daily | Once or twice daily |
| GI side effects | More common | Significantly less |
| Absorption | Proximal small bowel | Proximal colon |
| Efficacy | Equal | Equal |
✅ Take WITH or IMMEDIATELY AFTER the evening meal
| Action | Effect |
|---|---|
| ↓ Hepatic gluconeogenesis | Primary action - reduces fasting blood glucose (excess liver glucose = main cause of high FBS in T2DM) |
| ↓ Intestinal glucose absorption | Slows sugar absorption from gut |
| ↑ Peripheral glucose uptake | Improves insulin sensitivity in muscle |
| Does NOT stimulate insulin secretion | Therefore no hypoglycaemia risk when used alone |
| Phase | Dose | Timing |
|---|---|---|
| Starting dose | 500mg SR once daily | With evening meal |
| After 1-2 weeks | 500mg SR twice daily | With lunch + dinner |
| Titrate up | 1000mg SR once daily at night | With dinner |
| Maximum | 2000mg SR per day | Divided doses with meals |
Start low, go slow - this minimises GI side effects during initiation
| Side Effect | Details |
|---|---|
| GI symptoms (nausea, diarrhoea, abdominal bloating) | Most common; SR formulation significantly reduces this vs IR; take with food |
| Metallic taste | Common initially, resolves |
| Anorexia / weight loss | Beneficial in obese T2DM patients |
| Vitamin B12 deficiency | Long-term use; monitor B12 levels annually especially if anaemia or neuropathy develops |
| Lactic acidosis | Rare but potentially fatal; risk mainly with renal failure |
| Contraindication | Reason |
|---|---|
| eGFR <30 mL/min/1.73m² (severe renal failure) | Risk of lactic acidosis - drug accumulates |
| eGFR 30-45 | Use with caution; reduce dose |
| IV contrast dye procedures | Stop 48 hours before; restart 48 hours after (risk of contrast nephropathy → lactic acidosis) |
| Acute MI, sepsis, heart failure exacerbation | Acute renal failure risk |
| Alcohol excess | Increases lactic acidosis risk |
| Hepatic failure | Impaired lactate clearance |
| Instruction | Why |
|---|---|
| ✅ Take with evening meal, swallow whole | Reduces GI side effects, maintains SR coating |
| ✅ Never skip meals while on metformin | Increases GI side effects |
| ✅ Drink adequate water | Prevents GI issues |
| ❌ Do not crush/chew | Destroys slow-release mechanism → rapid dump of full dose → severe GI reaction |
| ❌ Do not take on empty stomach | Nausea, diarrhoea |
| ✅ Annual B12 monitoring | Long-term use depletes B12 |
| ✅ Check kidney function (eGFR) before starting and annually | Lactic acidosis prevention |
| Parameter | Frequency |
|---|---|
| HbA1c | Every 3 months until target, then 6-monthly |
| Fasting blood glucose | Weekly initially, then monthly |
| Serum creatinine / eGFR | Before starting, then annually |
| Vitamin B12 | Annually (especially after 3+ years of use) |
| LFTs | Baseline |
Bottom line for Metformin SR 500: Take ONE tablet with evening dinner, swallow whole, never on empty stomach. It does NOT cause hypoglycaemia alone. Start with once daily and increase as tolerated. It is the safest, most evidence-based first-line diabetes drug available.
Metformin500 can be taken before food?
| Timing | What Happens |
|---|---|
| Before food (empty stomach) | Drug absorbs rapidly → high peak concentration → nausea, vomiting, diarrhoea, abdominal cramps in most patients |
| With food (first bite) | Food slows absorption → lower peak concentration → GI side effects significantly reduced |
| After food | Also acceptable - slightly lower peak, further reduces GI upset |
Textbook recommendation (Lippincott Pharmacology): "GI adverse effects can be alleviated by titrating the dose slowly and administering the drug with meals."
| Formulation | Timing |
|---|---|
| Metformin 500 IR | With the first bite of food or during the meal |
| Metformin 500 SR | With or immediately after evening meal; swallow whole |
Simple rule to tell patients: "Never take Metformin on an empty stomach. Always take it with your food - not before, not 1 hour after. With food means with food."
23y old female pt came to the opd with left side abdominal pain
Create a clinical assessment checklist for left-sided abdominal pain in young women